Pharmaceutical

MilliporeSigma opens two new mRNA manufacturing facilities in Germany

MilliporeSigma has opened two new messenger ribonucleic acid (mRNA) drug substance manufacturing facilities in Germany.

Sep 27, 2023 - 20:00
MilliporeSigma opens two new mRNA manufacturing facilities in Germany
MilliporeSigma has opened two new messenger ribonucleic acid (mRNA) drug substance manufacturing facilities in Germany.
Read the original article

Tags:

Previous Article

Arcturus Therapeutics extends cystic fibrosis treatment deal

Next Article

Alfasigma to buy Intercept Pharmaceuticals for $794m

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: What will Novo’s VC do with its influx of cash? Don’t expect obesity investments

STAT+: What will Novo’s VC do with its influx of cash? ...

Sep 28, 2023

Manufacturing inspections down in China amid arrest fears and no access

Manufacturing inspections down in China amid arrest fea...

Jun 2, 2024

Opinion: Listen: Sniffing out the power, and limits, of the placebo effect

Opinion: Listen: Sniffing out the power, and limits, of...

Nov 1, 2023